| Authors: |
Ray-Coquard I; GINECO, Centre Léon Bérard, and Université Claude Bernard Lyon 1, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr., Kaminsky-Forrett MC; GINECO and Medical Oncology, Institut de Cancérologie de Lorraine - Alexis Vautrin, Vandoeuvre Les Nancy, France., Ohkuma R; Cancer Immune Surveillance and Therapeutic Targeting Team, Centre de Recherche en Cancérologie de Lyon (CRCL) INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France.; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., de Montfort A; Biostatistics Unit, Clinical Research and Innovation Department, Centre Léon Bérard, Lyon, France., Joly F; Medical Oncology, Centre François Baclesse and UniCaen University, Caen, France., Treilleux I; GINECO and Department of Anatomopathology, Centre Léon Bérard, Lyon, France.; Department of Biopathology (PATHEC), Centre Léon Bérard, Lyon, France., Ghamry-Barrin S; Lyon Immunotherapy for Cancer Laboratory (LICL), CRCL, INSERM 1052-CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France., Bello-Roufai D; Medical Oncology Department, Institut Curie, Saint-Cloud, France., Saintigny P; Université Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, CRCL, Lyon, France.; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; CASTING - Cancer Dynamics, Adaptation and Modeling, INRIA, INSERM, Ecole Normale Supérieure de Lyon, Centre Léon Bérard, CNRS and University Claude Bernard Lyon 1, Lyon, France., Angelergues A; GINECO and Medical Oncology Department, Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France., Michon L; Université Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, CRCL, Lyon, France.; CASTING - Cancer Dynamics, Adaptation and Modeling, INRIA, INSERM, Ecole Normale Supérieure de Lyon, Centre Léon Bérard, CNRS and University Claude Bernard Lyon 1, Lyon, France., Hardy-Bessard AC; GINECO and Medical Oncology, CARIO-HPCA, Plérin, France., Attignon V; Plateforme de Génomique des Cancers, CRCL, Centre Léon Bérard, INSERM U1052, CNRS UMR 5286, Université Claude Bernard Lyon 1, Lyon, France., Auclair J; Plateforme de Génomique des Cancers, CRCL, Centre Léon Bérard, INSERM U1052, CNRS UMR 5286, Université Claude Bernard Lyon 1, Lyon, France., Chemin G; Cancer Immune Surveillance and Therapeutic Targeting Team, Centre de Recherche en Cancérologie de Lyon (CRCL) INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France., Lainé A; EMS Team, Centre Léon Bérard, Lyon, France., Péré H; Microbiology Department, Virology Unit, APHP, Hôpital Européen Georges-Pompidou, Paris, France.; Université Paris Cité, INSERM UMRS1138 Functional Genomics of Solid Tumors Laboratory, Paris, France., Veyer D; Microbiology Department, Virology Unit, APHP, Hôpital Européen Georges-Pompidou, Paris, France.; Université Paris Cité, INSERM UMRS1138 Functional Genomics of Solid Tumors Laboratory, Paris, France., Savoye AM; GINECO and Medical Oncology Department, Institut Jean Godinot, Reims, France., Berthet J; Cancer Immune Surveillance and Therapeutic Targeting Team, Centre de Recherche en Cancérologie de Lyon (CRCL) INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), CRCL, INSERM 1052-CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France., Caux C; Cancer Immune Surveillance and Therapeutic Targeting Team, Centre de Recherche en Cancérologie de Lyon (CRCL) INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), CRCL, INSERM 1052-CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France., Lecuru F; GINECO and Breast, Gynecology and Reconstructive Surgery Unit, Institut Curie, Paris Cité University, Paris, France., Dubois B; Cancer Immune Surveillance and Therapeutic Targeting Team, Centre de Recherche en Cancérologie de Lyon (CRCL) INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), CRCL, INSERM 1052-CNRS UMR5286, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France., Bétrian S; GINECO and Medical Oncology, Institut Claudius Regaud, Toulouse, France. |
